FirstWord Pharma – referenced from The Irish Times

Please link to the article below which was posted in Sept 2014 by firstwordpharma.com website.

The post refers to an Irish Times article reporting that Sigmoid Pharma entered into an exclusive licence agreement with Pendopharm to commercialise its product to treat ulcerative colitis. The agreement amounts to a €5m investment.

You can read the full article by clicking on the button below.

FirstWord Pharma Article – “Sigmoid Pharma raises €5m investment from Pendopharm”

Share This Post!

If you are interested in becoming an Investor or seeking investment, then please contact us.